• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

季节性流感病毒与新型甲型H7N9流感病毒之间T细胞表位的保守性

Conservation of T cell epitopes between seasonal influenza viruses and the novel influenza A H7N9 virus.

作者信息

Mao Huawei, Yen Hui-Ling, Liu Yinping, Lau Yu-Lung, Malik Peiris J S, Tu Wenwei

机构信息

Department of Paediatrics, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China.

出版信息

Virol Sin. 2014 Jun;29(3):170-5. doi: 10.1007/s12250-014-3473-3. Epub 2014 Jun 17.

DOI:10.1007/s12250-014-3473-3
PMID:24950786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7102336/
Abstract

A novel avian influenza A (H7N9) virus recently emerged in the Yangtze River delta and caused diseases, often severe, in over 130 people. This H7N9 virus appeared to infect humans with greater ease than previous avian influenza virus subtypes such as H5N1 and H9N2. While there are other potential explanations for this large number of human infections with an avian influenza virus, we investigated whether a lack of conserved T-cell epitopes between endemic H1N1 and H3N2 influenza viruses and the novel H7N9 virus contributes to this observation. Here we demonstrate that a number of T cell epitopes are conserved between endemic H1N1 and H3N2 viruses and H7N9 virus. Most of these conserved epitopes are from viral internal proteins. The extent of conservation between endemic human seasonal influenza and avian influenza H7N9 was comparable to that with the highly pathogenic avian influenza H5N1. Thus, the ease of inter-species transmission of H7N9 viruses (compared with avian H5N1 viruses) cannot be attributed to the lack of conservation of such T cell epitopes. On the contrary, our findings predict significant T-cell based cross-reactions in the human population to the novel H7N9 virus. Our findings also have implications for H7N9 virus vaccine design.

摘要

一种新型甲型H7N9禽流感病毒最近在长江三角洲地区出现,并导致130多人患病,且病情往往较为严重。这种H7N9病毒似乎比之前的甲型禽流感病毒亚型(如H5N1和H9N2)更容易感染人类。虽然对于禽流感病毒导致大量人类感染存在其他潜在解释,但我们调查了地方性H1N1和H3N2流感病毒与新型H7N9病毒之间缺乏保守的T细胞表位是否与这一现象有关。在此我们证明,地方性H1N1和H3N2病毒与H7N9病毒之间存在一些保守的T细胞表位。这些保守表位大多来自病毒内部蛋白。地方性人类季节性流感与禽流感H7N9之间的保守程度与高致病性禽流感H5N1相当。因此,H7N9病毒(与禽流感H5N1病毒相比)跨物种传播的易感性不能归因于此类T细胞表位缺乏保守性。相反,我们的研究结果预测人群中针对新型H7N9病毒会出现显著的基于T细胞的交叉反应。我们的研究结果对H7N9病毒疫苗设计也有启示。

相似文献

1
Conservation of T cell epitopes between seasonal influenza viruses and the novel influenza A H7N9 virus.季节性流感病毒与新型甲型H7N9流感病毒之间T细胞表位的保守性
Virol Sin. 2014 Jun;29(3):170-5. doi: 10.1007/s12250-014-3473-3. Epub 2014 Jun 17.
2
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.针对人类甲型流感病毒的人类细胞毒性T淋巴细胞群体对禽H5N1流感病毒的交叉识别。
J Virol. 2008 Jun;82(11):5161-6. doi: 10.1128/JVI.02694-07. Epub 2008 Mar 19.
3
Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.新型禽源甲型流感病毒(H7N9)的转录组特征:特异性宿主反应以及介于禽源(H5N1和H7N7)与人源(H3N2)病毒之间的反应及其对治疗方案的意义
mBio. 2014 Feb 4;5(1):e01102-13. doi: 10.1128/mBio.01102-13.
4
Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.针对季节性甲型流感病毒的人细胞毒性 T 淋巴细胞与新出现的 H7N9 病毒发生交叉反应。
J Virol. 2014 Feb;88(3):1684-93. doi: 10.1128/JVI.02843-13. Epub 2013 Nov 20.
5
Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design.T细胞表位的交叉保守性:如今对(H7N9)流感疫苗设计更为重要。
Hum Vaccin Immunother. 2014;10(2):256-62. doi: 10.4161/hv.28135. Epub 2014 Feb 13.
6
Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population.泰国人群中针对 H7N9 和 H5N1 禽流感病毒的交叉反应性抗体。
Asian Pac J Allergy Immunol. 2017 Mar;35(1):20-26. doi: 10.12932/AP0788.
7
Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.先前暴露于人类甲型流感病毒中的免疫原性肽可能会影响禽流感 H5N1 和 H7N9 病毒感染病例的年龄分布。
Epidemiol Infect. 2019 Jan;147:e213. doi: 10.1017/S095026881900102X.
8
A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.一种复制缺陷型流感病毒,同时携带 H5 和 H7 血凝素,可在小鼠中预防 H5N1 和 H7N9 感染。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.02154-20.
9
Preexisting CD4+ T-cell immunity in human population to avian influenza H7N9 virus: whole proteome-wide immunoinformatics analyses.人类群体中针对甲型H7N9禽流感病毒的预先存在的CD4+ T细胞免疫:全蛋白质组范围的免疫信息学分析
PLoS One. 2014 Mar 7;9(3):e91273. doi: 10.1371/journal.pone.0091273. eCollection 2014.
10
Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.针对人类感染的禽流感病毒的异源种保护与偏倚的交叉 T 细胞反应相关。
mBio. 2018 Aug 7;9(4):e01408-18. doi: 10.1128/mBio.01408-18.

引用本文的文献

1
Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.先前暴露于人类甲型流感病毒中的免疫原性肽可能会影响禽流感 H5N1 和 H7N9 病毒感染病例的年龄分布。
Epidemiol Infect. 2019 Jan;147:e213. doi: 10.1017/S095026881900102X.
2
The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice.帕米膦酸对致死性甲型H7N9禽流感病毒感染的人源化小鼠的治疗效果
PLoS One. 2015 Aug 18;10(8):e0135999. doi: 10.1371/journal.pone.0135999. eCollection 2015.
3
Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.新城疫病毒载体H7和H5活疫苗可保护鸡免受H7N9或H5N1禽流感病毒的攻击。
J Virol. 2015 Jul;89(14):7401-8. doi: 10.1128/JVI.00031-15. Epub 2015 Apr 29.

本文引用的文献

1
Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract.新型甲型 H7N9 禽流感病毒的趋向性和先天宿主反应:人类呼吸道的离体和体外培养分析。
Lancet Respir Med. 2013 Sep;1(7):534-42. doi: 10.1016/S2213-2600(13)70138-3. Epub 2013 Jul 25.
2
The genesis and source of the H7N9 influenza viruses causing human infections in China.中国感染人类的 H7N9 流感病毒的起源和来源。
Nature. 2013 Oct 10;502(7470):241-4. doi: 10.1038/nature12515. Epub 2013 Aug 21.
3
Biological features of novel avian influenza A (H7N9) virus.新型甲型 H7N9 禽流感病毒的生物学特征。
Nature. 2013 Jul 25;499(7459):500-3. doi: 10.1038/nature12379. Epub 2013 Jul 3.
4
Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.新兴的禽源 H7N9 预测具有低免疫原性:对流感疫苗设计的影响。
Hum Vaccin Immunother. 2013 May;9(5):950-6. doi: 10.4161/hv.24939. Epub 2013 May 1.
5
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases.中国人群中感染甲型禽流感病毒 H7N9 和 H5N1 的比较流行病学:基于实验室确诊病例的人群研究。
Lancet. 2013 Jul 13;382(9887):129-37. doi: 10.1016/S0140-6736(13)61171-X. Epub 2013 Jun 24.
6
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity.人感染甲型 H7N9 禽流感病毒:临床严重程度评估。
Lancet. 2013 Jul 13;382(9887):138-45. doi: 10.1016/S0140-6736(13)61207-6. Epub 2013 Jun 24.
7
Timely estimates of influenza A H7N9 infection severity.甲型H7N9流感感染严重程度的及时评估。
Lancet. 2013 Jul 13;382(9887):106-8. doi: 10.1016/S0140-6736(13)61447-6. Epub 2013 Jun 24.
8
Detection of mild to moderate influenza A/H7N9 infection by China's national sentinel surveillance system for influenza-like illness: case series.中国流感样病例国家监测系统对轻度至中度甲型 H7N9 流感感染的检测:病例系列。
BMJ. 2013 Jun 24;346:f3693. doi: 10.1136/bmj.f3693.
9
Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013.2013 年 3 月至 4 月中国人间感染甲型 H7N9 禽流感的疾病严重程度与年龄的初步推断。
Euro Surveill. 2013 May 9;18(19):20475.
10
Clinical findings in 111 cases of influenza A (H7N9) virus infection.111 例甲型 H7N9 流感病毒感染的临床特征。
N Engl J Med. 2013 Jun 13;368(24):2277-85. doi: 10.1056/NEJMoa1305584. Epub 2013 May 22.